Steroid-induced CSC may only occur in vulnerable patients

Article

Steroid-induced central serous chorioretinopathy (CSC) may only occur in select patients who are vulnerable, rather than having a dose-dependent effect, according to a recent study published in Investigative Ophthalmology & Visual Science

Steroid-induced central serous chorioretinopathy (CSC) may only occur in select patients who are vulnerable, rather than having a dose-dependent effect, according to a recent study published in Investigative Ophthalmology & Visual Science.

For this prospective, pilot study, researchers from the Seoul National University College of Medicine and Bundang Hospital measured choroidal thickness in 35 eyes in 18 patients treated with high-dose systemic corticosteroid pulse therapy (>500 mg/d) at baseline, 1 day, 1 week and 1 month after corticosteroids were administered. Blood pressures were measured four times daily for the first 5 days of treatment as well. High-dose corticosteroid therapy concentrations delivered were 19.5 mg/kg, for a mean of 5.2 days.

At baseline, the mean subfoveal choroidal thickness was 259.8 μm (range: 86.4 to 394.7 μm). No significant changes in choroidal thickness were seen at day 1, week 1, or month 1 after treatment (P = 0.117). In only one patient who presented at baseline with pigment epithelial detachment, bilateral focal subretinal fluid was seen and showed central serous chorioretinopathy, with a 13.1% increase in subfoveal choroidal thickness.

To view an abstract of this study, click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.